This advanced GLP-1/GIP medication helps regulate appetite, blood sugar, and metabolism for effective weight management
Sodium-glucose co-transporter 1 (SGLT1) differentially regulates gluconeogenesis and GLP-1 receptor (GLP-1R) expression in different diabetic rats: a preliminary validation of the hypothesis of SGLT1 bridge as an indication for surgical diabetes
Nonfatal stroke risk was decreased by 16% and hospitalization for heart failure by 10%
Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimers disease
If you experience persistent vomiting, inability to maintain hydration, or marked inability to meet caloric needs, especially during dose titration, contact your healthcare provider promptly
Not every trial was powered or designed to show superiority, and differences in trial design and in participant baseline characteristics make it challenging to compare results across trials